Jin David
- SEC CIK
- 0001930732
In the past year, 1 open-market purchase filing worth $237.12 and no sales.
Current role at each company
- FBIO Fortress Biotech, Inc.Chief Financial Officeras of Jun 24, 2026
- MBIO Mustang Bio, Inc.Directoras of Dec 30, 2025
- ATXI Avenue Therapeutics, Inc.Interim PFO and COOas of Sep 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $237.12
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$237.12
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jin David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MBIO Mustang Bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 (view filing) | Dec 30 | Same day | Jin DavidDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.0001 | +247 | $0.96 | +$237.12 | +633.3%286 after |
FBIO Fortress Biotech, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2024 (view filing) | Jul 10 | 2 days | Jin DavidChief Financial Officer | PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +500 | $7.50 | +$3.75K | New position500 after | |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Jin DavidChief Financial Officer | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +35.9K | $0.84 | +$30.2K | +2.6%1.44M after | |
| Dec 2, 2022 (view filing) | Nov 30 | 2 days | Jin DavidChief Financial Officer | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +5.00K | $0.56 | +$2.80K | +0.4%1.40M after |